Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?

Saved in:
Bibliographic Details
Title: Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?
Authors: Bang LL; Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: llbang@health.sdu.dk., Madsen LW; Department of Infectious Diseases, Odense University Hospital and Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark; Unit for Infectious Diseases, Department of Medicine, Sygehus Lillebælt, Kolding, Denmark; Department of Regional Health Research, University of Southern Denmark, Denmark. Electronic address: Lone.Wulff.Madsen@rsyd.dk., Pedersen RM; Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: rune.pedersen@rsyd.dk., Nilsson AC; Department of Clinical Immunology, Odense University Hospital, and Research Unit for Clinical Immunology, University of Southern Denmark, Odense, Denmark. Electronic address: christine.nilsson@rsyd.dk., Johansen IS; Department of Infectious Diseases, Odense University Hospital and Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark. Electronic address: Isik.Somuncu.Johansen@rsyd.dk., Andersen TE; Department of Clinical Microbiology, Odense University Hospital, and Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: thandersen@health.sdu.dk.
Source: Journal of infection and public health [J Infect Public Health] 2024 Sep; Vol. 17 (9), pp. 102512. Date of Electronic Publication: 2024 Aug 07.
Publication Type: Letter
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101487384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-035X (Electronic) Linking ISSN: 18760341 NLM ISO Abbreviation: J Infect Public Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1876-035X
DOI:10.1016/j.jiph.2024.102512